Eisai’s H3 Biomedicine appoints new CMO

H3 Biomedicine, Inc. (H3), precision medicine research & development subsidiary of Eisai Co has announced the a...

February 24, 2020 | Monday | News
BIO cancels Asia conference in Tokyo amid COVID-19 outbreak

The Biotechnology Innovation Organization (BIO) has announced, it is canceling the annual BIO Asia conference in Tokyo s...

February 24, 2020 | Monday | News
BitOne enhances remote medical services with 5G technology

Japan based BitOne Group Company Limited and IBO Telecom Company Limited, a Hong Kong-based subsidiary of IBO Techn...

February 19, 2020 | Wednesday | News
Chugai receives Orphan Drug Designation for RG6042

Japan based Chugai Pharmaceutical has announced that the Ministry of Health, Labour and Welfare (MHLW) has des...

February 18, 2020 | Tuesday | News
Researchers investigate cancer genomic landscape of Japan

Tokyo Medical and Dental University (TMDU), ACT Genomics (Taipei, Taiwan), and ACTmed (Japan) launched a joint clinical ...

February 17, 2020 | Monday | News
Japan explores muscular dystrophy associated cardiomyopathy

In a study recently published in Nature Communications, scientists at Japan based Okayama University describe ...

February 14, 2020 | Friday | News
Foundation Medicine & Chugai announce partnership with NCC

Foundation Medicine, Inc. and Chugai Pharmaceutical Co., Ltd. have entered into an agreement with the&nbs...

February 13, 2020 | Thursday | News
Nippon Shinyaku inks new agreement for prostate cancer treatment

Japan based Nippon Shinyaku Co., LTD. has announced that Janssen Pharmaceutical K.K. and Nippon Shinyaku entered into a ...

February 12, 2020 | Wednesday | News
Japan suggests combined drug treatment for lung cancer

Researchers at Japan based Kanazawa University report in the Journal of Thoracic Oncology a promising novel ap...

February 11, 2020 | Tuesday | News
Chugai collaborates with National Cancer Center

Japanese firm Chugai Pharmaceutical Co., Ltd. has announced that it has entered into an agreement with National Cancer C...

February 10, 2020 | Monday | News
Santen, Verily to develop unique ophthalmic devices

Japan based Santen Pharmaceutical Co., Ltd. and US based Verily, an Alphabet company, have announced the establishment o...

February 7, 2020 | Friday | News
Sumitomo Dainippon, Exscientia begin clinical study of AI based OCD drug

Japan based Sumitomo Dainippon Pharma Co., Ltd. and UK based Exscientia Ltd. have announced that a phase I clinical stud...

February 3, 2020 | Monday | News
Japan unveils herbal medicines to treat stomach disorders

In a recent study researchers at Okayama University, Japan illustrate the potential of berberine, a herbal Chinese medic...

January 30, 2020 | Thursday | News
Kitakyushu Hospital to initiate Senhance Digital Laparoscopy Program

TransEnterix, Inc. a medical device company that is digitizing the interface between the surgeon and the patient to impr...

January 30, 2020 | Thursday | News
AgeX accelerates hypoimmunogenic cells development in Japan

US based AgeX Therapeutics, a biotechnology company developing therapeutics for human aging and regeneration, announced ...

January 31, 2020 | Friday | News
JT to market CORECTIM in Japan to treat atopic dermatitis

Japan Tobacco Inc. and Torii Pharmaceutical Co., Ltd. (Torii) have announced that JT has received manufacturing and mark...

January 30, 2020 | Thursday | News
Eisai and PGDx jointly start R&D of cancer genetics panel test

Japanese firm Eisai Co., Ltd., has entered into a joint research and development agreement with Personal Genome Diagnost...

January 29, 2020 | Wednesday | News
Eisai’s DAYVIGO gets approval in Japan to treat insomnia

Japanese firm Eisai Co., Ltd has obtained the manufacturing and marketing approval in Japan for its in-house discovered ...

January 28, 2020 | Tuesday | News